Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
J Clin Endocrinol Metab. 2013 Jun;98(6):2326-36. doi: 10.1210/jc.2013-1039. Epub 2013 May 29.
Studies examining the association between subclinical hypothyroidism and mortality have yielded conflicting results. Emerging data suggest these associations may depend upon underlying congestive heart failure (CHF) and/or race, but this has not been empirically determined.
Our objective was to examine the association between subclinical hypothyroidism and hypothyroidism overall with mortality according to pre-existing CHF and race.
We examined the associations of subclinical hypothyroidism (TSH higher than assay upper limit of normal; total T4 within reference) and hypothyroidism overall (TSH higher than assay upper limit of normal; total T4 below lower limit of normal or within reference) with all-cause mortality among Third National Health and Nutrition Examination Survey participants stratified by CHF and race using multivariable Cox models. To confirm whether differences between strata were statistically significant, we tested for interaction on the basis of CHF (separately) and race by likelihood ratio testing.
There were 14 130 (95.0%) euthyroid controls and 749 (5.0%) participants with hypothyroidism, 691 (4.6%) of whom had subclinical disease. Subclinical hypothyroidism vs euthyroidism was associated with greater mortality in those with CHF but not in those without: adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) = 1.44 (1.01-2.06) and 0.97 (0.85-1.11), respectively (P interaction = .03). Similar findings were observed for hypothyroidism overall. Hypothyroidism overall vs euthyroidism was associated with greater mortality in Black participants (HR = 1.44 [95% CI = 1.03-2.03]) but not in non-Blacks (HR = 0.95 [95% CI = 0.83-1.08]) (P interaction = .03).
Among participants with CHF, subclinical hypothyroidism and hypothyroidism overall are associated with greater death risk. Additional studies are needed to confirm findings and explore possible mechanisms for the differential hypothyroidism-mortality association across race.
研究亚临床甲状腺功能减退症与死亡率之间的关系得出的结果相互矛盾。新出现的数据表明,这些关联可能取决于潜在的充血性心力衰竭(CHF)和/或种族,但这尚未得到经验性证实。
我们的目的是根据预先存在的 CHF 和种族,检查亚临床甲状腺功能减退症(TSH 高于检测上限;总 T4 在参考范围内)和甲状腺功能减退症(TSH 高于检测上限;总 T4 低于正常下限或在参考范围内)与所有原因死亡率之间的关联。
我们使用多变量 Cox 模型,根据充血性心力衰竭和种族对第三次国家健康和营养检查调查参与者进行分层,检查亚临床甲状腺功能减退症(TSH 高于检测上限;总 T4 在参考范围内)和甲状腺功能减退症(TSH 高于检测上限;总 T4 低于正常下限或在参考范围内)与所有原因死亡率之间的关联。为了确认层间差异是否具有统计学意义,我们根据似然比检验分别对 CHF(单独)和种族进行交互检验。
有 14130 名(95.0%)甲状腺功能正常对照者和 749 名(5.0%)甲状腺功能减退者,其中 691 名(4.6%)患有亚临床疾病。亚临床甲状腺功能减退症与甲状腺功能正常相比,在患有 CHF 的患者中与更高的死亡率相关,但在没有 CHF 的患者中则没有:调整后的危险比(HR)(95%置信区间[CI])= 1.44(1.01-2.06)和 0.97(0.85-1.11),差异有统计学意义(P 交互=0.03)。对于甲状腺功能减退症整体也观察到类似的发现。与甲状腺功能正常相比,甲状腺功能减退症与黑人参与者的死亡率升高相关(HR = 1.44 [95%CI = 1.03-2.03]),但与非黑人参与者无关(HR = 0.95 [95%CI = 0.83-1.08])(P 交互=0.03)。
在患有 CHF 的参与者中,亚临床甲状腺功能减退症和甲状腺功能减退症与更高的死亡风险相关。需要进一步研究以证实这些发现,并探讨种族间甲状腺功能减退症与死亡率的差异关联的可能机制。